Weight Loss

Biography

Biography: U. Deniz Dincer

Abstract

Visceral fat is thought to be the source of adiposopathy, which is characterised by chronic inflammation and necrosis. It produces and releases many bioactive peptides named adipokines, which play important roles in energy production, vascular homeostasis, immunity and metabolic syndrome. When healthy adipocytes are transformed to “sick adipocytes”, all the hormones, cytokines, chemokines and growth factors released from fat may change. Thus, a new perspective related to developing new approach against obesity and metabolic syndrome focuses on “reversing inflammation in adipose tissue”, which could break the link between inflammation and adiposopathy-associated complications. When clinicians and scientists aim to create an “avant-garde” human body, obesity cannot include on that picture; it is more than aesthetic outfit but certainly related associated complications. Reversing adipocyte inflammation is a “new therapeutic approach” which could reverse adiposity-associated complications in metabolic syndrome, type II diabetes and atherosclerotic cardiovascular disease.